Wall Street Experts
ver. ZuMIgo(08/25)
4D Molecular Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -168
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
6 |
14 |
7 |
14 |
18 |
3 |
21 |
0 |
| Przychód Δ r/r |
0.0% |
144.0% |
-50.6% |
94.8% |
32.5% |
-82.7% |
562.3% |
-99.8% |
| Marża brutto |
100.0% |
100.0% |
-454.2% |
-289.6% |
83.3% |
-24.0% |
72.3% |
100.0% |
| EBIT (mln) |
-11 |
-10 |
-51 |
-57 |
-71 |
-110 |
-113 |
-188 |
| EBIT Δ r/r |
0.0% |
-7.7% |
388.2% |
11.6% |
25.9% |
54.3% |
2.6% |
66.4% |
| EBIT (%) |
-194.7% |
-73.6% |
-726.7% |
-416.3% |
-395.5% |
-3516.5% |
-544.6% |
-507678.4% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
-6 |
0 |
0 |
| EBITDA (mln) |
-11 |
-10 |
-39 |
-55 |
-71 |
-110 |
-107 |
-188 |
| EBITDA(%) |
-183.9% |
-68.7% |
-565.2% |
-405.7% |
-395.5% |
-3516.5% |
-516.9% |
-507678.4% |
| Podatek (mln) |
-0 |
1 |
4 |
-0 |
-3 |
-6 |
0 |
0 |
| Zysk Netto (mln) |
-11 |
-10 |
-53 |
-57 |
-68 |
-101 |
-101 |
-161 |
| Zysk netto Δ r/r |
0.0% |
-14.9% |
454.3% |
6.8% |
20.8% |
48.0% |
-0.2% |
59.5% |
| Zysk netto (%) |
-193.8% |
-67.6% |
-757.8% |
-415.4% |
-378.6% |
-3230.3% |
-486.6% |
-434778.4% |
| EPS |
-0.76 |
-0.76 |
-2.0 |
-2.12 |
-2.46 |
-3.12 |
-2.58 |
-2.98 |
| EPS (rozwodnione) |
-0.76 |
-0.76 |
-2.0 |
-2.12 |
-2.46 |
-3.12 |
-2.58 |
-2.98 |
| Ilośc akcji (mln) |
15 |
13 |
26 |
27 |
28 |
32 |
39 |
54 |
| Ważona ilośc akcji (mln) |
15 |
13 |
26 |
27 |
28 |
32 |
39 |
54 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |